Sobi
Sobi (Swedish Orphan Biovitrum AB) is a leading international biopharmaceutical company dedicated to rare diseases. The company focuses on transforming the lives of people with rare diseases through innovative treatments in haematology, immunology, and specialty care. With a global workforce and operations in more than 30 countries, Sobi is a key player in the specialized medicine sector, headquartered in Stockholm, Sweden. Sobi has a well-established presence in Spain, with its main operations centered in Madrid. The Spanish team is responsible for market access, commercial strategy, and medical affairs within the Iberian market. For international professionals, Sobi provides a highly professional and mission-led environment where English is often the primary language for regional coordination, making it a viable option for expats with experience in the pharmaceutical industry.
Company History
Sobi was formed in 2010 through the merger of Biovitrum and Swedish Orphan International. The company's heritage in biotechnology dates back to the 1930s through its predecessor KabiVitrum.
For International Professionals
- Specializes in rare diseases, offering niche career opportunities in high-growth therapeutic areas.
- The Spanish headquarters is located in Madrid, a major hub for the European life sciences industry.
- As a global organization, Sobi promotes a diverse workforce and often facilitates cross-border collaboration.
- The company is known for a purpose-driven culture focused on patient impact and medical innovation.